Please login to the form below

Not currently logged in
Email:
Password:

Itulazax

This page shows the latest Itulazax news and features for those working in and with pharma, biotech and healthcare.

ALK-Abello debuts its birch pollen allergy therapy in Germany

ALK-Abello debuts its birch pollen allergy therapy in Germany

Key market for the new product. Danish drugmaker ALK-Abello has launched its tree pollen immunotherapy Itulazax in Germany, its first market, following its European approval earlier this year. ... The company expects to roll Itulazax out next in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....